Neuberger High Yield Strategies Fund Inc. (NHS) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
NHS steht fuer Neuberger High Yield Strategies Fund Inc., ein Financial Services-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Bewertet mit 47/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 16. März 2026Neuberger High Yield Strategies Fund Inc. (NHS) Finanzdienstleistungsprofil
Neuberger High Yield Strategies Fund Inc. (NHS) is a US-based closed-end fund focusing on global high-yield debt, managed by Neuberger Berman. With a high dividend yield of 15.60% and investments across sectors like auto parts, healthcare, and telecom, NHS offers income-seeking investors exposure to fixed-income markets.
Investmentthese
Neuberger High Yield Strategies Fund Inc. presents a compelling investment case for income-seeking investors, driven by its high dividend yield of 15.60% and a focus on high-yield debt securities. The fund's attractive profit margin of 75.7% suggests efficient management and strong income generation from its investments. Key catalysts include the ongoing demand for high-yield investments in a low-interest-rate environment and the fund's ability to capitalize on undervalued debt opportunities. However, potential risks include increased credit risk associated with high-yield debt during economic downturns and fluctuations in interest rates that could impact the fund's net asset value. The fund's beta of 0.75 indicates lower volatility compared to the broader market, which may appeal to risk-averse investors. Continued monitoring of the fund's performance, asset allocation, and macroeconomic conditions is crucial for assessing its long-term investment potential.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- High Dividend Yield: NHS boasts a dividend yield of 15.60%, making it a noteworthy option for income-focused investors.
- Strong Profit Margin: The fund exhibits a high profit margin of 75.7%, indicating efficient management and profitable investment strategies.
- Low Beta: With a beta of 0.75, NHS demonstrates lower volatility compared to the overall market, potentially offering a more stable investment.
- Global Diversification: NHS invests in fixed income markets across the globe, providing diversification benefits and exposure to various economies.
- Experienced Management: Managed by Neuberger Berman Investment Advisers LLC, the fund benefits from the expertise and resources of a well-established asset management firm.
Wettbewerber & Vergleichsunternehmen
Staerken
- High dividend yield.
- Strong profit margin.
- Experienced management team.
- Global diversification.
Schwaechen
- Exposure to high-yield debt risk.
- Sensitivity to interest rate changes.
- Potential for credit losses.
- Closed-end fund structure can lead to trading at a discount to NAV.
Katalysatoren
- Ongoing: Continued demand for high-yield investments in a low-interest-rate environment.
- Ongoing: Fund's ability to capitalize on undervalued debt opportunities.
- Upcoming: Potential for increased dividend payouts due to strong earnings.
- Upcoming: Strategic partnerships with institutional investors (within 1-2 years).
- Upcoming: Launch of new high-yield products (within 18-24 months).
Risiken
- Potential: Increased credit risk associated with high-yield debt during economic downturns.
- Potential: Fluctuations in interest rates that could impact the fund's net asset value.
- Ongoing: Competition from other asset management firms.
- Potential: Regulatory changes that could impact the fund's operations.
- Ongoing: Market volatility and uncertainty.
Wachstumschancen
- Expansion into Emerging Markets: NHS can explore growth opportunities by increasing its exposure to high-yield debt in emerging markets. These markets often offer higher yields compared to developed markets, but also come with increased risks. By carefully selecting investments in emerging markets, NHS can potentially enhance its returns and diversify its portfolio. The emerging market debt market is projected to grow to $3 trillion by 2028, presenting a significant opportunity for NHS to expand its asset base.
- Focus on Sustainable Investing: NHS can attract socially responsible investors by incorporating environmental, social, and governance (ESG) factors into its investment process. By focusing on companies with strong ESG profiles, NHS can align its investments with the growing demand for sustainable investing. The ESG investing market is expected to reach $50 trillion by 2025, indicating a substantial opportunity for NHS to tap into this growing trend.
- Leveraging Technology for Enhanced Analysis: NHS can leverage advanced technologies such as artificial intelligence and machine learning to improve its credit analysis and risk management capabilities. By using AI-powered tools, NHS can identify undervalued debt securities and better assess the creditworthiness of potential investments. This can lead to improved investment performance and reduced risk. The adoption of AI in asset management is projected to increase significantly over the next few years, providing NHS with a competitive advantage.
- Strategic Partnerships with Institutional Investors: NHS can forge strategic partnerships with institutional investors such as pension funds and endowments to secure long-term capital commitments. By partnering with these investors, NHS can enhance its stability and reduce its reliance on retail investors. Institutional investors are increasingly allocating capital to alternative investment strategies, including high-yield debt, presenting an opportunity for NHS to attract significant investments. These partnerships could materialize within the next 1-2 years.
- Development of New High-Yield Products: NHS can develop new high-yield products tailored to specific investor needs and preferences. This could include creating specialized funds focused on particular sectors or geographies. By offering a wider range of products, NHS can attract a broader investor base and increase its assets under management. The demand for specialized high-yield products is growing as investors seek more targeted investment solutions. New product offerings could be launched within the next 18-24 months.
Chancen
- Expansion into emerging markets.
- Focus on sustainable investing.
- Leveraging technology for enhanced analysis.
- Strategic partnerships with institutional investors.
Risiken
- Economic downturns.
- Increased competition.
- Regulatory changes.
- Rising interest rates.
Wettbewerbsvorteile
- Established brand and reputation of Neuberger Berman.
- Experienced management team with expertise in high-yield investing.
- Access to proprietary research and analysis.
- Diversified portfolio reduces risk.
Ueber NHS
Neuberger High Yield Strategies Fund Inc., established on July 28, 2003, is a closed-end fixed income mutual fund managed by Neuberger Berman Investment Advisers LLC, a subsidiary of Neuberger Berman LLC. The fund's primary objective is to generate current income by investing in fixed income markets worldwide. NHS focuses on high yield debt securities, commonly known as junk bonds, issued by companies across diverse sectors. These sectors include auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution. The fund's investment strategy involves identifying and capitalizing on opportunities in the global high-yield debt market. By investing in a diversified portfolio of high-yield securities, NHS aims to mitigate risk while maximizing income potential for its investors. The fund's management team employs a rigorous research process to evaluate creditworthiness and assess the relative value of potential investments. Neuberger Berman Investment Advisers LLC leverages its expertise and resources to actively manage the fund's portfolio, adjusting allocations based on market conditions and investment opportunities. This active management approach allows NHS to adapt to changing market dynamics and seek to deliver consistent returns to its shareholders. The fund is domiciled in the United States and trades on the New York Stock Exchange.
Was das Unternehmen tut
- Invests in global fixed income markets.
- Focuses on high yield debt securities.
- Manages a diversified portfolio of bonds.
- Seeks to generate current income for investors.
- Employs active management strategies.
- Conducts credit analysis to assess risk.
Geschaeftsmodell
- Generates income through interest payments from bond holdings.
- Earns management fees based on assets under management (AUM).
- Utilizes leverage to enhance returns.
- Actively trades securities to optimize portfolio performance.
Branchenkontext
Neuberger High Yield Strategies Fund Inc. operates within the asset management industry, which is characterized by intense competition and evolving market dynamics. The industry is influenced by factors such as interest rates, economic growth, and investor sentiment. Funds like NHS compete with other closed-end funds, ETFs, and mutual funds for investor capital. The high-yield debt market, in particular, is sensitive to credit spreads and default rates. As investors search for yield in a low-interest-rate environment, high-yield strategies can attract significant inflows, but they also carry higher risks compared to investment-grade bonds. The fund's performance is closely tied to the overall health of the global economy and the creditworthiness of the companies in which it invests.
Wichtige Kunden
- Retail investors seeking income.
- Institutional investors looking for high-yield exposure.
- Wealth management clients.
- Retirement savers.
Finanzdaten
Chart & Info
Neuberger High Yield Strategies Fund Inc. (NHS) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
-
NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES RIGHTS OFFERING AND SUMMARY OF TERMS
prnewswire.com · 12. März 2026
-
NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES EARLY DECLARATION OF REGULAR MONTHLY DISTRIBUTION
prnewswire.com · 12. März 2026
-
NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
prnewswire.com · 27. Feb. 2026
-
Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) Stock Price Crosses Above 50 Day Moving Average – Time to Sell?
defenseworld.net · 24. Feb. 2026
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer NHS.
Kursziele
Wall-Street-Kurszielanalyse fuer NHS.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von NHS auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Aktuelle Nachrichten
NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES RIGHTS OFFERING AND SUMMARY OF TERMS
NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES EARLY DECLARATION OF REGULAR MONTHLY DISTRIBUTION
NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) Stock Price Crosses Above 50 Day Moving Average – Time to Sell?
Fuehrung: Joseph Vincent Amato
President and Chief Investment Officer - Equities
Joseph V. Amato serves as the President and Chief Investment Officer of Equities at Neuberger Berman. He is a member of the firm’s Investment Oversight Committee. Amato joined Neuberger Berman in 1993 and has held various leadership positions within the company. His extensive experience in the financial industry spans several decades, providing him with deep insights into market dynamics and investment strategies. He is known for his expertise in equity investments and his ability to navigate complex market conditions.
Erfolgsbilanz: During his tenure at Neuberger Berman, Joseph Amato has overseen significant growth and innovation in the firm's equity division. He has been instrumental in developing and implementing investment strategies that have delivered strong returns for clients. His leadership has contributed to Neuberger Berman's reputation as a leading asset management firm. He has successfully guided the firm through various market cycles, demonstrating his ability to adapt to changing conditions and deliver consistent results.
Neuberger High Yield Strategies Fund Inc. Aktie: Wichtige Fragen beantwortet
What are the key factors to evaluate for NHS?
Neuberger High Yield Strategies Fund Inc. (NHS) currently holds an AI score of 47/100, indicating low score. Key strength: High dividend yield.. Primary risk to monitor: Potential: Increased credit risk associated with high-yield debt during economic downturns.. This is not financial advice.
How frequently does NHS data refresh on this page?
NHS prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven NHS's recent stock price performance?
Recent price movement in Neuberger High Yield Strategies Fund Inc. (NHS) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: High dividend yield.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider NHS overvalued or undervalued right now?
Determining whether Neuberger High Yield Strategies Fund Inc. (NHS) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying NHS?
Before investing in Neuberger High Yield Strategies Fund Inc. (NHS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding NHS to a portfolio?
Potential reasons to consider Neuberger High Yield Strategies Fund Inc. (NHS) depend on individual investment goals and risk tolerance. A key strength identified by analysis: High dividend yield.. Additionally: Strong profit margin.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of NHS?
Yes, most major brokerages offer fractional shares of Neuberger High Yield Strategies Fund Inc. (NHS) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track NHS's earnings and financial reports?
Neuberger High Yield Strategies Fund Inc. (NHS) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for NHS earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- AI analysis pending, limiting comprehensive insights.
- Financial data based on available information as of 2026-03-16.